Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
Autore F, Visentin A, Deodato M, Vitale C, Galli E, Fresa A, Fazzi R, Sanna A, Olivieri J, Scortechini I, Del Principe MI, Sportoletti P, Schiattone L, Maschio N, Facchinelli D, Marchesi F, Coscia M, Tedeschi A, Trentin L, Innocenti I, Candoni A, Busca A, Pagano L, Laurenti L. Autore F, et al. Among authors: scortechini i. Am J Hematol. 2024 May;99(5):982-984. doi: 10.1002/ajh.27247. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38343033 No abstract available.
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study.
Poloni A, Capelli D, Trappolini S, Costantini B, Montanari M, Gini G, Scortechini I, Mancini G, Discepoli G, Leoni P, Olivieri A. Poloni A, et al. Among authors: scortechini i. Br J Haematol. 2010 Jul;150(1):119-21. doi: 10.1111/j.1365-2141.2010.08168.x. Epub 2010 Apr 5. Br J Haematol. 2010. PMID: 20377587 Free article. Clinical Trial. No abstract available.
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation.
Olivieri A, Lucesole M, Capelli D, Gini G, Montanari M, Candela M, Troiani E, Scortechini I, Poloni A, Leoni P. Olivieri A, et al. Among authors: scortechini i. Biol Blood Marrow Transplant. 2005 Aug;11(8):627-36. doi: 10.1016/j.bbmt.2005.05.002. Biol Blood Marrow Transplant. 2005. PMID: 16041313 Free article.
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.
Montefusco V, Spina F, Patriarca F, Offidani M, Bruno B, Montanari M, Mussetti A, Sperotto A, Scortechini I, Dodero A, Fanin R, Valagussa P, Corradini P. Montefusco V, et al. Among authors: scortechini i. Biol Blood Marrow Transplant. 2013 Mar;19(3):424-8. doi: 10.1016/j.bbmt.2012.10.032. Epub 2012 Nov 8. Biol Blood Marrow Transplant. 2013. PMID: 23142330 Free article. Clinical Trial.
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib.
Saraceni F, Scortechini I, Mancini G, Mariani M, Federici I, Gaetani M, Barbatelli P, Minnucci ML, Bagnarelli P, Olivieri A. Saraceni F, et al. Among authors: scortechini i. Transpl Infect Dis. 2021 Feb;23(1):e13401. doi: 10.1111/tid.13401. Epub 2020 Jul 14. Transpl Infect Dis. 2021. PMID: 32629531 Free PMC article.
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
Lanza F, Lemoli RM, Olivieri A, Laszlo D, Martino M, Specchia G, Pavone V, Imola M, Pasini A, Milone G, Scortechini I, Todisco E, Guggiari E, Cascavilla N, Martinelli G, Rambaldi A, Bosi A. Lanza F, et al. Among authors: scortechini i. Transfusion. 2014 Feb;54(2):331-9. doi: 10.1111/trf.12265. Epub 2013 Jun 19. Transfusion. 2014. PMID: 23781769
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
Messina G, Giaccone L, Festuccia M, Irrera G, Scortechini I, Sorasio R, Gigli F, Passera R, Cavattoni I, Filippi AR, Schianca FC, Pini M, Risitano AM, Selleri C, Levis A, Mordini N, Gallamini A, Pastano R, Casini M, Aglietta M, Montanari M, Console G, Boccadoro M, Ricardi U, Bruno B; Gruppo Italiano Trapianti di Midollo. Messina G, et al. Among authors: scortechini i. Biol Blood Marrow Transplant. 2012 Oct;18(10):1600-7. doi: 10.1016/j.bbmt.2012.03.012. Epub 2012 Apr 5. Biol Blood Marrow Transplant. 2012. PMID: 22484666 Free article.
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study.
Marinelli Busilacchi E, Costantini A, Viola N, Costantini B, Olivieri J, Butini L, Mancini G, Scortechini I, Chiarucci M, Poiani M, Poloni A, Leoni P, Olivieri A. Marinelli Busilacchi E, et al. Among authors: scortechini i. Biol Blood Marrow Transplant. 2018 Feb;24(2):267-275. doi: 10.1016/j.bbmt.2017.10.039. Epub 2017 Nov 8. Biol Blood Marrow Transplant. 2018. PMID: 29128554 Free article. Clinical Trial.
31 results